粪便挥发性有机化合物与肠易激综合征患者饮食干预反应相关
这项2×2析因随机对照试验纳入93例完成研究的肠易激综合征患者,比较低FODMAP饮食与安慰饮食、多菌株益生菌与安慰剂4周的效果。低FODMAP饮食组反应率高于安慰饮食组(80% vs 45%,P<.001),益生菌与安慰剂无差异。基线粪便挥发性有机化合物谱分类低FODMAP饮食反应的平均准确率为97%,分类益生菌反应为89%。
要点
- 低FODMAP饮食组反应率80%(37/46)高于安慰饮食组45%(21/47),P<.001。
- 益生菌组反应率63%(31/49)与安慰剂组61%(27/44)无显著差异,P=.850。
- 基线粪便VOC谱分类低FODMAP饮食反应准确率97%(95%CI 96%-99%),分类益生菌反应89%(95%CI 86%-92%)。
核心结论
- 粪便挥发性有机化合物谱分析是一种低成本、非侵入性工具,可能用于预测肠易激综合征患者对低FODMAP饮食和益生菌的反应并识别其作用机制。
研究设计与样本
- 研究为2×2析因随机对照试验,纳入符合Rome III标准的肠易激综合征成人患者。
- 患者随机接受低FODMAP饮食咨询(n=46)或安慰饮食建议(n=47)4周,每组再随机接受多菌株益生菌或安慰剂补充。
- 最终分析纳入完成研究的93例患者(63例女性),基线及4周末采集粪便,用气相色谱传感器装置分析VOC。
- VOC谱通过小波变换及基于随机森林的特征选择流程确定,并用偏最小二乘分类器以10折交叉验证评估分类准确率。
主要发现
- 低FODMAP饮食组反应37/46(80%)高于安慰饮食组21/47(45%),P<.001。
- 益生菌组反应31/49(63%)与安慰剂组27/44(61%)无显著差异,P=.850。
- 饮食与补充剂干预之间无交互作用。
- 基线VOC谱含15个特征分类低FODMAP饮食反应,平均准确率97%(95%CI 96%-99%);含10个特征分类益生菌反应,平均准确率89%(95%CI 86%-92%)。
- 治疗结束时的模型达到相似的预测力和准确率。
关键数值与推荐
- 反应定义为经验证的肠易激综合征症状评分系统评分降低50分或以上。
- 低FODMAP饮食指低果聚糖、低半乳糖寡糖、低乳糖、低果糖和低多元醇饮食。
临床怎么用
- 原文结论认为粪便VOC谱分析可能用于预测肠易激综合征患者对低FODMAP饮食和益生菌的反应并识别其作用机制。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Dietary interventions are effective in management of patients with irritable bowel syndrome (IBS), although responses vary. We investigated whether fecal levels of volatile organic compounds (VOCs) associate with response to dietary interventions in patients with IBS. METHODS: Adults who fulfilled the Rome III criteria for IBS were recruited to a 2x2 factorial randomized controlled trial. Patients were randomly assigned to a group counselled to follow a diet low in fructans, galacto-oligosaccharides, lactose, fructose, and polyols (low-FODMAP diet, n = 46) or a group that received placebo dietary advice (sham diet, n = 47) for 4 weeks. Patients from each group were also given either a multi-strain probiotic or placebo supplement. Response was defined as a reduction of 50 points or more on the validated IBS symptom scoring system. Fecal samples were collected from participants at baseline and end of the 4-week study period; VOCs were analyzed by a gas-chromatography sensor device. VOC profiles were determined using a pipeline involving wavelet transformation followed by feature selection based on random forest. A partial least squares classifier was constructed to classify VOC profiles by response and accuracies were determined using 10-fold cross-validation. RESULTS: Data from 93 patients who completed the study (63 female) were used in the final analysis. More patients responded to the low-FODMAP diet (37/46, 80%) than the sham diet (21/47, 45%) (P < .001), but there was no difference in response between patients given the probiotic (31/49, 63%) vs the placebo (27/44, 61%) (P = .850), with no interaction between the diet and supplement interventions. At baseline, VOC profiles contained 15 features that classified response to the low-FODMAP diet with a mean accuracy of 97% (95% CI, 96%-99%) and 10 features that classified response to probiotic with a mean accuracy of 89% (95% CI, 86%-92%). End of treatment models achieved similar predictive powers and accuracies. CONCLUSION: Fecal VOC profiling is a low cost, non-invasive tool that might be used to predict responses of patients with IBS to low-FODMAP diet and probiotics and identify their mechanisms of action. ISRCTN registry no: 02275221.
引用
- Rossi M, Aggio R, Staudacher HM, et al. Volatile Organic Compounds in Feces Associate With Response to Dietary Intervention in Patients With Irritable Bowel Syndrome. Clin Gastroenterol Hepatol. 2017. PMID: 28993261. doi:10.1016/j.cgh.2017.09.055
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。